COX-3: Fact or fancy?
- 30 November 2004
- journal article
- editorial
- Published by Elsevier in Joint Bone Spine
- Vol. 71 (6), 451-453
- https://doi.org/10.1016/j.jbspin.2004.02.003
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics?Prostaglandins, Leukotrienes & Essential Fatty Acids, 2003
- ResolvinsThe Journal of Experimental Medicine, 2002
- Is there a place for non-selective NSAIDs in the treatment of arthritis?Joint Bone Spine, 2002
- Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivityNature, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?Clinical Infectious Diseases, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory diseaseThe Lancet, 2000
- Inducible cyclooxygenase may have anti-inflammatory propertiesNature Medicine, 1999
- Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)Nature, 1972